A study in Ontario found a nearly threefold increase in schizophrenia cases linked to cannabis use disorder (CUD) after legalization. Young men (19–24) had the highest...
Rovi has gained FDA approval for its drug Risvan to treat schizophrenia in adults. The approval led to a nearly 3% surge in Rovi's stock. Risvan,...